Clinical Trial Update: Brazilian Lung Immunotherapy Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a Brazilian lung immunotherapy study focusing on lung neoplasm has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Neoplasm

Snippet

Sponsor: Hospital Israelita Albert Einstein | Conditions: Lung Neoplasm | Phase 2 | Status: COMPLETED